Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Optimising CAR-T Cell Therapy in RRMM
7
Mins
August 2025
The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…
Read more
7
Mins
29 Aug 2025
Optimising CAR-T Cell Therapy in RRMM
The ‘Mastering the Relapsed Refractory Multiple Myeloma (RRMM) Treatment Landscape: Removing Barriers and Unleashing the Potential of…
6
Mins
31 Jul 2025
Recent Developments in CLL Research
Talha Munir reviews the recent developments in chronic lymphocytic leukaemia research presented at the 2024 American Society of Hematology…
11
Mins
31 Jul 2025
Optimal Care of Unfit Patients with FTL3+ AML
Acute myeloid leukaemia (AML) is a rapidly progressing myeloid neoplasm caused by the clonal expansion of primitive haematopoietic stem…
8
Mins
24 Jul 2025
CLL Highlights from EHA 2025
This review article explores key research highlights and new data on CLL presented at EHA 2025, considering how the latest clinical…
5
Mins
24 Jul 2025
Gene Therapy: Living With(out) Haemophilia?
Since research on human gene therapy began, the expectations regarding its potential in treating haemophilia have been high. Haemophilia…
3
Mins
24 Jul 2025
Re-evaluating European Haemophilia Standards
TEST In this feature, the authors critically analyse the European standards for Haemophilia Treatment Centres (HTC), examining their…
8
Mins
24 Jul 2025
Rituximab in Adults with Autoimmune Haematological Disorders
Rituximab, a monoclonal anti-CD20 antibody, has proven to be an excellent therapeutic agent for haematological diseases. Low-dose…
11
Mins
24 Jul 2025
100 Years of von Willebrand Disease
von Willebrand disease (VWD) is considered the most common inherited bleeding disorder, even surpassing haemophilia A. Nevertheless, VWD…
Loading posts...
1
2
3
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View